KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Invested Capital (2016 - 2025)

Historic Invested Capital for Arbutus Biopharma (ABUS) over the last 17 years, with Q3 2025 value amounting to $77.4 million.

  • Arbutus Biopharma's Invested Capital fell 2759.0% to $77.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.4 million, marking a year-over-year decrease of 2759.0%. This contributed to the annual value of $97.4 million for FY2024, which is 816.09% down from last year.
  • As of Q3 2025, Arbutus Biopharma's Invested Capital stood at $77.4 million, which was down 2759.0% from $83.0 million recorded in Q2 2025.
  • Over the past 5 years, Arbutus Biopharma's Invested Capital peaked at $169.4 million during Q4 2021, and registered a low of $77.4 million during Q3 2025.
  • For the 5-year period, Arbutus Biopharma's Invested Capital averaged around $121.1 million, with its median value being $119.3 million (2023).
  • Per our database at Business Quant, Arbutus Biopharma's Invested Capital surged by 6617.21% in 2021 and then plummeted by 3223.9% in 2025.
  • Over the past 5 years, Arbutus Biopharma's Invested Capital (Quarter) stood at $169.4 million in 2021, then dropped by 19.23% to $136.9 million in 2022, then dropped by 22.53% to $106.0 million in 2023, then dropped by 8.16% to $97.4 million in 2024, then dropped by 20.51% to $77.4 million in 2025.
  • Its Invested Capital stands at $77.4 million for Q3 2025, versus $83.0 million for Q2 2025 and $79.2 million for Q1 2025.